Winai Ratanasuwan Selected Research

Winai Ratanasuwan Research Topics

9	Infections 09/2022 - 10/2007
6	HIV Infections (HIV Infection) 01/2016 - 03/2003
4	Coinfection 11/2017 - 09/2013
3	Hepatitis B 01/2018 - 01/2016
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 02/2004
3	Hepatitis C 01/2016 - 01/2014
2	Body Weight (Weight, Body) 01/2023 - 06/2019
2	Opportunistic Infections (Opportunistic Infection) 01/2015 - 02/2004
1	Proteinuria 01/2023
1	COVID-19 09/2022
1	Cognitive Dysfunction 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2019
1	Malaria 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Anemia 01/2017
1	Inflammation (Inflammations) 01/2016
1	Hyperglycemia 10/2012
1	Hypoglycemia (Reactive Hypoglycemia) 10/2012
1	Exanthema (Rash) 01/2012
1	Nausea 11/2009
1	Dizziness (Lightheadedness) 11/2009
1	Headache (Headaches) 11/2009
1	Viremia 06/2004
1	Hepatitis A (Hepatitis, Infectious) 06/2004
1	Cerebral Toxoplasmosis 02/2004
1	Cryptococcosis 02/2004
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 02/2004

6	Tenofovir (Viread)FDA Link 01/2023 - 01/2014
5	RNA (Ribonucleic Acid)IBA 01/2018 - 06/2004
5	Raltegravir Potassium FDA Link 01/2018 - 10/2007
3	NucleosidesIBA 01/2013 - 06/2004
2	Emtricitabine (Emtriva)FDA Link 01/2018 - 11/2017
2	Stavudine (Zerit)FDA LinkGeneric 01/2014 - 06/2004
2	Reverse Transcriptase InhibitorsIBA 01/2013 - 04/2008
1	LipidsIBA 01/2023
1	VaccinesIBA 09/2022
1	CobicistatIBA 06/2019
1	elvitegravirIBA 06/2019
1	emtricitabine tenofovir alafenamideIBA 06/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019
1	Antiviral Agents (Antivirals)IBA 03/2016
1	N- (5- (1- methyl- 1H- pyrazol- 4- yl)- napthalene- 2- carbonyl)guanidineIBA 03/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Lamivudine (Epivir)FDA Link 09/2013
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2013
1	Insulin (Novolin)FDA Link 10/2012
1	Nevirapine (Viramune)FDA Link 01/2012
1	efavirenz (Sustiva)FDA Link 11/2009
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2008
1	Human immunodeficiency virus 1 p31 integrase proteinIBA 10/2007
1	Hepatitis A AntibodiesIBA 06/2004
1	CytokinesIBA 03/2003

7	Therapeutics 01/2019 - 06/2004
3	Art Therapy 01/2016 - 01/2012
1	Polypharmacy 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 09/2012
1	Chemoprevention 02/2004
1	Secondary Prevention 02/2004